Liver iron concentrations and urinary hepcidin in -thalassemia
Open accessAbstract
BACKGROUND AND OBJECTIVES: Patients with beta-thalassemia, like those with genetic hemochromatosis, develop iron overload due to increased iron absorption, and their iron burden is further exacerbated by transfusion therapy. Hepcidin, a hepatic hormone, regulates systemic iron homeostasis by inhibiting the absorption of iron from the diet and the recycling of iron by macrophages. In turn, hepcidin release is increased by iron loading and inhibited by erythropoietic activity. Hepcidin deficiency is the cause of iron overload in most forms of hereditary hemochromatosis. We sought to determine hepcidin's role in the pathogenesis of iron overload in b-thalassemia. DESIGN AND METHODS: We assessed the degree of iron overload in thalassemia intermedia and major patients by measuring hepatic iron concentration in liver biopsy samples and serum ferritin, estimated erythropoietic drive by assaying soluble transferrin receptor and serum erythropoietin levels and correlated these with urinary hepcidin measurements. RESULTS: Urinary hepcidin levels in beta-thalassemia demonstrate severe hepcidin deficiency in thalassemia intermedia. There was a strong inverse relationship between urinary hepcidin levels and both erythropoietin and soluble transferrin receptor, markers of erythropoietic activity. In contrast, hepcidin levels were elevated in thalassemia major, presumably due to transfusions that reduce erythropoietic drive and deliver a large iron load. Despite similar liver iron concentrations in the two conditions, serum ferritin was much lower in thalassemia intermedia. INTERPRETATION AND CONCLUSIONS: In thalassemia intermedia, high erythropoietic drive causes severe hepcidin deficiency. The lack of hepcidin results in hyperabsorption of dietary iron, but also in iron depletion of macrophages, lowering their secretion of ferritin and, consequently, serum ferritin levels. In contrast, in thalassemia major, transfusions decrease erythropoietic drive and increase the iron load, resulting in relatively higher hepcidin levels. In the presence of higher hepcidin levels, dietary iron absorption is moderated and macrophages retain iron, contributing to higher serum ferritin. In the future, hepcidin measurements may allow a more accurate assessment of the degree of iron overload and the maldistribution of iron in thalassemia.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In untransfused patients with β-thalassaemia, blood hepcidin levels are very low despite high iron concentrations and iron deposition, due to suppression by mediators from expanded erythroblasts.
“Despite high concentrations of iron and deposition of iron in the liver and other vital organs, the blood level of hepcidin in untransfused patients with β-thalassaemia is very low38–40, owing to suppression by mediators originating from the expanded erythroblast population in the bone marrow12,41.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 26 · Cited by 365
Research works printed but not linked: 7
- [1]1. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in β -thalassaemia intermedia. Lancet 1979;2:819-21.
- [2]2. Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, Charoenlarp P, et al. The effect of erythroid hyperplasia on iron balance. Blood 1988; 71:1124-9.
- [3]3. Olivieri NF. The β -thalassemias. N Engl J Med 1999;341:99-109.
- [4]4. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006;37:12-20.
- [5]5. Rund D, Rachmilewitz E. β -thalassemia. N Engl J Med 2005; 353: 113546.
- [6]6. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91:727-32.
- [7]7. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood 2005; 105: 4103-5.
- Authors
- Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E.
- Affiliations
- University of Cagliari (IT)
- University of California, Los Angeles (US)
- Corresponding author
- Nemeth, E.
- Venue
- Haematologica
- Published
- 2007-05-01
- Volume
- 92
- Issue
- 5
- Pages
- 583-588
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W1983048915
- Cited by
- 365
- References
- 26
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 14 · 2023: 15 · 2022: 13 · 2021: 15 · 2020: 14 · 2019: 13 · 2018: 19 · 2017: 21 · 2016: 21 · 2015: 32 · 2014: 28 · 2013: 23 · 2012: 17
- FWCI
- 18.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Haematologica (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
- Keywords
- beta-thalassemia, iron overload, hepcidin, urinary hepcidin, thalassemia intermedia, thalassemia major, liver iron concentration, serum ferritin, soluble transferrin receptor, erythropoietin, iron homeostasis, transfusion therapy
- MeSH terms
- Adolescent, Adult, Blood Transfusion, Combined Modality Therapy, Deferoxamine, Erythropoiesis, Female, Ferritins, Gene Expression Regulation, Humans, Intestinal Absorption, Iron, Iron Chelating Agents, Liver, Macrophages, Male, Severity of Illness Index, Transferrin, Chelation Therapy, beta-Thalassemia, Iron Overload, Iron, Dietary, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review